Caresite®

Luer-activated valve developed as needle-free injection port in IV applications

Caresite® is a needleless connector that can be used for infusion and transfusion therapy. It is designed for aspiration, injection, or intravenous infusion of fluids upon insertion of a male luer fitting.

Caresite® allows multiple usage through activation of the needle-free connector by attaching a luer slip / luer lock connector such as a syringe or IV tubing.

Advantages

Luer-Slip and Luer-Lock compatible

  • Easy access for Luer-Slip and Luer-Lock connections. Suitable for several IV procedures (e.g. Luer Lock connections, etc.).1 Do not leave connected luer slip syringes unattended.

Easy disinfection

  • Smooth surfaces designed for easy cleaning.5
  • Caresite is alcohol resistant.1

Easy to inspect and to flush

  • Open fluid path designed to minimize areas where bacteria can collect. 
  • Clear design helps verify proper flush. 
  • Can be effectively flushed of blood or fluids.7

Blood and lipid compatible

  • Caresite® is compatible with lipids and blood.1,8

Average fluid displacement 0.029 ml (positive)

  • Designed to reduce the risk of catheter occlusion.1,9,10,11,12

Designed to minimize slips and touch contamination

  • Ergonomic design provides easy access by allowing a good grip and easy connection.1

Highly pressure resistant

  • The standalone Caresite® LAD is suitable for use with power injectors which allows more flexibility. Pressure resistance up to 400 psi @ 15 mL / sec.1

Technical data

  • Flow rate 208 mL / min1
  • Priming volume 0.22 mL1
  • Not made with PVC1
  • Not made with DEHP1
  • Not made with Latex / Natural rubber1

Tested for 1,000 activations

  • Allows multiple access for direct aspiration or fluid injection.13

MRI compatible or conditional

  • No metal parts contained.1

Compatibility

  • Compatible with SwabCap – disinfection cap.1

Patient population

  • The device can be used for all patients for which infusion therapy is prescribed. No gender or age-related limitations. There are no patient population restrictions.1

 

Risk prevention:

Sharps Injury

  • Needle-free systems are designed to provide convenient and safe needle-free IV access for injection, aspiration or parallel infusion.4,6

Air Embolism

  • A closed system helps to reduce the risk of air embolism due to the self-sealing valve which avoids intake of air. 2,3,5,14

Chemical contamination

  • A closed system reduces the risk of chemical contamination as the valve prevents spillage / drug exposure. 2,3,5,14

Microbial contamination / Airborne contamination / Touch contamination

  • Product does not allow the entry of external contaminants in the system, forming an effective microbial barrier when exposed to a microbial burden. Effective barrier to microbial contamination when swabbed with alcohol pad per the instruction for use. Helps to prevent bloodstream infections. Swabbable valve forms a closed system as it is designed to prevent microbial ingress and the escape of contaminants.2,5
  1. Internal data
  2. Test report - Evaluation of the microbial barrier performance of Caresite® valve against sporesog Bacillussubtilis signed by Prof. Dr. med. M.Exner and Dr. rer. nat. J. Gebel, Report DMT 2013-412, 11.12.2013
  3. Test Report - Closed system test by means of Sodium Fluorescein signed by Dr. rer. nat. J. Brünke Quality Labs BT GmbH Nuremberg, Report 1678.2-1, 28.05.2013
  4. American Nurses Association – Independent Study Module: Needlestick Safety and Prevention written by Mary Foley, MS, RN and Annemarie T. Leyden, EdD, RN
  5. White Paper: CARESITE® Luer Access Device (LAD): 7- Day Microbial Barrier Performance, B. Braun Medical Inc., Bethlehem, PA., 15-5669 SW, 2017
  6. Review Article - Review on Needle Free Drug Delivery Systems, International Journal of Pharma Research & Review, written by Bhagyashri Chavan, Abha Doshi, Yashwant Malode, Balu Misal, Sept 2013; 2(9):30-36
  7. White Paper: CARESITE Luer Access Device: Blood Clearance Test of the Needleless Connector, B. Braun Medical Inc., Bethlehem, PA., CS05_ 07/10_EB, 2010
  8. White Paper: CARESITE Luer Access Device: Mechanical Hemolysis Test of the Needleless Connector, B. Braun Medical Inc., Bethlehem, PA., CS06_ 07/10_EB, 2010
  9. Guidelines: Infusion Therapy Standards of Practice, page 152 published in Journal of Infusion Nursing (January/February 2016, Volume 39, Number 1S)
  10. Study: Efficacy of a “saline only” flush protocol utilizing the Ultrasite® positive displacement device. Susan Silverstein, RN, CRNI, Nurse Consultant, Omnicare Infusion Services of Northern Illinois, January 2003
  11. Study: Journal of Vascular Access Devices, Volume 5, Issue 4, 2000, Page 31-33, The effects of positive pressure devices on catheter occlusions, Loretta Berger RN, CRNI
  12. Study: Leone M, Dillon R. Catheter outcomes in home infusion. JIN March/April 2008 Vol 31, No2.
  13. Whitepaper: Caresite Confirmation 1,000 activations (2019)
  14. Test report - Evaluation of the microbial barrier performance  of the female valve Caresite® by touch contamination with  Staphylococcus aureus signed by Prof. Dr. med. M.Exner and  Dr. rer. nat. J. Gebel, Report DMT 2014-194, 09.12.2014
  15. Nygren O. Olofsson E. Johannson L. NIOSH Definition of Closed-System Drug-Transfer Devices. Oxford Journals. Annals of Occupational Hygiene. 2009: 53(5): 549. doi: 10.1093/annhyg/mep030
Please enable marketing cookies to enable Youtube Video

Caresite® – in short words